Fig. 1From: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunitiesEpigenetic regulatory drugs promote anti-tumor immune signaling to synergize with PD1/PD-L1 immunotherapyBack to article page